Evidence map›Paper›PMID 39554592›Full record

ArticleJournal of cancer research updates2024

Studying the Role of Novel Carbon Nano Tubes as a Therapeutic Agent to Treat Triple Negative Breast Cancer (TNBC) - an

Kamal Asadipour, Narendra Banerjee, Jazmine Cuffee, Karrington Perry, Shennel Brown, Anasua Banerjee, Erik Armstrong, Stephen Beebe, Hirendra Banerjee

Abstract read
In one paragraph

Article in Journal of cancer research updates, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kamal AsadipourFrank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA-23529, USA.
Narendra BanerjeeDepartment of Natural Sciences, Pharmaceutical and Health Sciences, Elizabeth City State University Campus of The University of North Carolina, Elizabeth City, NC 27909, USA.
Jazmine CuffeeDepartment of Natural Sciences, Pharmaceutical and Health Sciences, Elizabeth City State University Campus of The University of North Carolina, Elizabeth City, NC 27909, USA.
Karrington PerryDepartment of Natural Sciences, Pharmaceutical and Health Sciences, Elizabeth City State University Campus of The University of North Carolina, Elizabeth City, NC 27909, USA.
Shennel BrownDepartment of Natural Sciences, Pharmaceutical and Health Sciences, Elizabeth City State University Campus of The University of North Carolina, Elizabeth City, NC 27909, USA.
Anasua BanerjeeDepartment of Cell Biology, Harvard University, Boston, MA-02115, USA.
Erik ArmstrongDepartment of Natural Sciences, Pharmaceutical and Health Sciences, Elizabeth City State University Campus of The University of North Carolina, Elizabeth City, NC 27909, USA.
Stephen BeebeFrank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA-23529, USA.
Hirendra BanerjeeDepartment of Natural Sciences, Pharmaceutical and Health Sciences, Elizabeth City State University Campus of The University of North Carolina, Elizabeth City, NC 27909, USA.

Funding

Elizabeth City State University Minority Access to Research Careers (E-MARC) UndeT34GM100831 · NIGMS · ELIZABETH CITY STATE UNIVERSITY · PI BANERJEE, HIRENDRA N · 2012 to 2022
$1.9M
NIGMS NIH HHS T34 GM100831
6 · The paper itself

Abstract

Triple Negative Breast Cancer (TNBC) is a malignant cancer with a very high mortality rate around the world. African American(AA) women are 28% more likely to die from triple-negative breast cancer (TNBC) than white women with the same diagnosis. AA patients are also more likely to be diagnosed at a later stage of the disease and have the lowest survival rates for any stage of diagnosis; There are very few existing anti TNBC drugs with therapeutic efficacy hence newer anti TNBC drug design and investigation is needed. Carbon Nano Tubes(CNT) in recent years have shown effective anti-cancer properties in various types of cancers as reported in peer reviewed journals. Henceforth, we did an investigation to study the anticancer properties of a novel CNT in both

Indexed as

Carbon Nano TubeEpithelial Mesenchymal TransitionNanotechnologySpheroidsTheragnosticTriple Negative Breast Cancer

Identifiers

PMID39554592
PMCPMC11568836

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.